SK280278B6 - Sterilná vodná farmaceutická kompozícia na parente - Google Patents

Sterilná vodná farmaceutická kompozícia na parente Download PDF

Info

Publication number
SK280278B6
SK280278B6 SK262-97A SK26297A SK280278B6 SK 280278 B6 SK280278 B6 SK 280278B6 SK 26297 A SK26297 A SK 26297A SK 280278 B6 SK280278 B6 SK 280278B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
lazaroid
composition according
lazaroids
tirilazad
Prior art date
Application number
SK262-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK26297A3 (en
Inventor
Ching-Chiang Su
David S. Baker
Susan M. Machkovech
Original Assignee
Pharmacia + Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia + Upjohn Company filed Critical Pharmacia + Upjohn Company
Publication of SK26297A3 publication Critical patent/SK26297A3/sk
Publication of SK280278B6 publication Critical patent/SK280278B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
SK262-97A 1994-09-01 1995-08-29 Sterilná vodná farmaceutická kompozícia na parente SK280278B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29937094A 1994-09-01 1994-09-01
US38225695A 1995-02-01 1995-02-01
PCT/US1995/010730 WO1996006618A1 (en) 1994-09-01 1995-08-29 Cosolvent parenteral formulation of tirilazad

Publications (2)

Publication Number Publication Date
SK26297A3 SK26297A3 (en) 1997-09-10
SK280278B6 true SK280278B6 (sk) 1999-10-08

Family

ID=26971187

Family Applications (1)

Application Number Title Priority Date Filing Date
SK262-97A SK280278B6 (sk) 1994-09-01 1995-08-29 Sterilná vodná farmaceutická kompozícia na parente

Country Status (23)

Country Link
US (1) US5858999A (cs)
EP (1) EP0778775B1 (cs)
JP (1) JPH10505063A (cs)
KR (1) KR100359556B1 (cs)
CN (1) CN1156962A (cs)
AT (1) ATE175875T1 (cs)
AU (1) AU696856B2 (cs)
BR (1) BR9508655A (cs)
CA (1) CA2196063A1 (cs)
CZ (1) CZ283875B6 (cs)
DE (1) DE69507493T2 (cs)
DK (1) DK0778775T3 (cs)
ES (1) ES2128761T3 (cs)
FI (1) FI970858A (cs)
GR (1) GR3029396T3 (cs)
HU (1) HUT76808A (cs)
MX (1) MX9701342A (cs)
NO (1) NO311405B1 (cs)
NZ (1) NZ292690A (cs)
PL (1) PL181244B1 (cs)
RU (1) RU2152789C2 (cs)
SK (1) SK280278B6 (cs)
WO (1) WO1996006618A1 (cs)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
US6017948A (en) * 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
PT1143962E (pt) * 1999-01-28 2005-03-31 Kurani Shashikant Prabhudas Solucao parenterica de propofol (2,6-di-isopropilfenol) e 2,5-di-o-metil-1,4;3,6-di-anidro-d-glucitol, como dissolvente
DE10010073B4 (de) 2000-02-28 2005-12-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verankerung für implantierbare Herzklappenprothesen
DE10010074B4 (de) 2000-02-28 2005-04-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vorrichtung zur Befestigung und Verankerung von Herzklappenprothesen
FR2828263B1 (fr) 2001-08-03 2007-05-11 Philipp Bonhoeffer Dispositif d'implantation d'un implant et procede d'implantation du dispositif
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
CA2550459C (en) * 2003-12-18 2009-12-15 Biomas, Ltd. Tellurium derivatives for prevention and treatment of neurodegenerative processes
EP1791535B1 (en) 2004-09-17 2008-07-30 BioMAS Ltd. Novel tellurium compounds and their use as immunomodulators
EP2471536A1 (en) * 2004-09-29 2012-07-04 Harbor BioSciences, Inc. Steroid analogs and characterization and treatment methods
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
DE102005051849B4 (de) 2005-10-28 2010-01-21 JenaValve Technology Inc., Wilmington Vorrichtung zur Implantation und Befestigung von Herzklappenprothesen
DE102005052628B4 (de) 2005-11-04 2014-06-05 Jenavalve Technology Inc. Selbstexpandierendes, flexibles Drahtgeflecht mit integrierter Klappenprothese für den transvaskulären Herzklappenersatz und ein System mit einer solchen Vorrichtung und einem Einführkatheter
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
WO2008138584A1 (en) 2007-05-15 2008-11-20 Jenavalve Technology Inc. Handle for manipulating a catheter tip, catheter system and medical insertion system for inserting a self-expandable heart valve stent
US9138315B2 (en) 2007-04-13 2015-09-22 Jenavalve Technology Gmbh Medical device for treating a heart valve insufficiency or stenosis
US8465540B2 (en) 2008-02-26 2013-06-18 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
US8398704B2 (en) 2008-02-26 2013-03-19 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US9168130B2 (en) 2008-02-26 2015-10-27 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US8317858B2 (en) 2008-02-26 2012-11-27 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
ES2903231T3 (es) 2008-02-26 2022-03-31 Jenavalve Tech Inc Stent para el posicionamiento y anclaje de una prótesis valvular en un sitio de implantación en el corazón de un paciente
DK2444092T3 (en) 2008-05-28 2015-09-28 Reveragen Biopharma Inc Non-hormonal steroidmodulatorer of NF-? B for the treatment of disease
US20100292779A1 (en) 2009-05-15 2010-11-18 Helmut Straubinger Device for compressing a stent and a system as well as a method for loading a stent into a medical delivery system
WO2011127048A2 (en) 2010-04-05 2011-10-13 Validus Biopharma NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
US11278406B2 (en) 2010-05-20 2022-03-22 Jenavalve Technology, Inc. Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
BR112012029896A2 (pt) 2010-05-25 2017-06-20 Jenavalve Tech Inc válcula cardíaca protética para endoprótese e endoprótese
JP6005168B2 (ja) 2011-10-21 2016-10-12 イエナバルブ テクノロジー インク 患者の身体への拡張型心臓弁ステント導入用カテーテルシステム、カテーテルシステムを備えた挿入システムおよび心臓弁欠陥治療用医療機器
WO2013171007A1 (en) 2012-05-16 2013-11-21 Jenavalve Technology Gmbh Catheter delivery system for introducing an expandable heart valve prosthesis and medical device for the treatment of a heart valve defect
CN103861090B (zh) * 2012-12-18 2017-06-13 美迪思生物科技(北京)有限公司 含蛋白或多肽的疏水溶液、其制备方法及用途
CN105491978A (zh) 2013-08-30 2016-04-13 耶拿阀门科技股份有限公司 用于假体瓣膜的径向可折叠框架及其制造方法
EP3288495B1 (en) 2015-05-01 2019-09-25 JenaValve Technology, Inc. Device with reduced pacemaker rate in heart valve replacement
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195918B (en) * 1984-03-14 1988-08-29 Jerome Corbiere Process for producing pharmaceutical compositions containing non-steroide antiflogistic active components
WO1987001706A2 (en) * 1985-09-12 1987-03-26 The Upjohn Company C20 through c26 amino steroids
US5175281A (en) * 1985-09-12 1992-12-29 The Upjohn Company Pharmaceutically active pyrimidinylpiperazinylsterioids
US4968675A (en) * 1988-10-28 1990-11-06 Upjohn Non-hemolytic lazaroid parenteral formulation
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
JP2002500616A (ja) * 1994-07-21 2002-01-08 ファルマシア・アンド・アップジョン・カンパニー 神経学的に活性なアミノステロイド
US5614515A (en) * 1994-11-17 1997-03-25 University Of Southern California Lazaroid-based compositions and method for preventing adhesion formation using the same

Also Published As

Publication number Publication date
DK0778775T3 (da) 1999-09-13
NO970935D0 (no) 1997-02-28
CZ55997A3 (en) 1997-06-11
PL181244B1 (pl) 2001-06-29
ES2128761T3 (es) 1999-05-16
HUT76808A (en) 1997-11-28
CZ283875B6 (cs) 1998-06-17
NO970935L (no) 1997-04-11
DE69507493D1 (de) 1999-03-04
ATE175875T1 (de) 1999-02-15
PL318901A1 (en) 1997-07-21
US5858999A (en) 1999-01-12
AU696856B2 (en) 1998-09-17
AU3493895A (en) 1996-03-22
BR9508655A (pt) 1997-08-12
CN1156962A (zh) 1997-08-13
WO1996006618A1 (en) 1996-03-07
EP0778775A1 (en) 1997-06-18
NO311405B1 (no) 2001-11-26
FI970858A0 (fi) 1997-02-28
EP0778775B1 (en) 1999-01-20
GR3029396T3 (en) 1999-05-28
KR100359556B1 (ko) 2002-12-18
NZ292690A (en) 1998-06-26
RU2152789C2 (ru) 2000-07-20
SK26297A3 (en) 1997-09-10
CA2196063A1 (en) 1996-03-07
FI970858A (fi) 1997-02-28
JPH10505063A (ja) 1998-05-19
DE69507493T2 (de) 1999-06-10
MX9701342A (es) 1997-05-31

Similar Documents

Publication Publication Date Title
SK280278B6 (sk) Sterilná vodná farmaceutická kompozícia na parente
EA036155B1 (ru) Инъекционные составы нейростероида, содержащие наночастицы
JP7232128B2 (ja) 抗菌剤及び抗炎症剤を含む眼内投与のための医薬組成物
EP4248971A2 (en) Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
JP2018030848A (ja) マクロライド抗生物質を投与するための非経口製剤
BR112012024673B1 (pt) Composição farmacêutica anestésica termogelificante e uso da mesma para a preparação de um medicamento para o tratamento de dor
US20150335704A1 (en) Pharmaceutical compositions comprising gels and methods for fabricating thereof
ES2221127T5 (es) Uso de acitromicina en el tratamiento topico de infecciones oculares.
WO1996003421A1 (en) Neurologically active aminosteroids
CA2903114A1 (en) Ophthalmic formulations
CN116265017A (zh) 一种包含本维莫德和皮质类固醇的药物组合物
TW202116326A (zh) 用於製備無菌眼用水性丙酸氟替卡松a型奈米晶體懸浮液之方法
US20200155450A1 (en) Pharmaceutical compositions comprising gels and methods for fabricating thereof
JP2001523248A (ja) １，２，４−ベンゾトリアジンオキシド配合物
EP3737378B1 (en) Palonosetron eye drops for the treatment or prevention of nausea and vomiting
CN110721152B (zh) 一种治疗动物皮肤寄生虫、真菌感染的缓释组合物
JPH11511479A (ja) １，２，４−ベンゾトリアジンオキシド製剤
US9339458B2 (en) Use of vaginal insulin sensitizing agents
EP3071202B1 (en) A combination of dosage units for use in the treatment of pre-term labour condition
WO2024125322A1 (zh) 防治过敏性和/或炎症性疾病的双嘧达莫及其制剂
EP2399583B1 (en) Use of vaginally-administered insulin sensitizing agents
WO2022206716A1 (zh) 含有促肾上腺皮质激素或其衍生物的药物及其用途
JP3538367B2 (ja) 皮膚組織障害治療・予防・改善用外用剤
CN101987103A (zh) 一种碳酸酐酶抑制剂的眼用组合物
WO2001080861A1 (en) Infertility or increasing fertility